SI-BONE competitors

Zippia score 4.8

SI-BONE main competitors are Onyx Pharmaceuticals, BioMarin, and Spectrum Pharmaceuticals.

Competitor Summary. See how SI-BONE compares to its main competitors:

Kyphon has the most employees (3,000).
Employees at Onyx Pharmaceuticals earn more than most of the competitors, with an average yearly salary of $95,378.

Work at SI-BONE?

Share your experience

SI-BONE vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
SI-BONE	2008	4.8	Santa Clara, CA	1	$167.2M	183
SIG Medical	2017	2.6	Hershey, PA	1	$54,000	2
St. Louis Spine Surgery Center	2007	3.1	Saint Louis, MO	1	$200,000	5
Globus Medical	2003	4.5	Audubon, PA	4	$2.5B	1,800
PDL BioPharma	1986	4.2	Incline Village, NV	1	$30.7M	75
Kyphon	1994	4.1	Sunnyvale, CA	1	-	3,000
Novartis Consumer Health Inc	-	4.5	Parsippany-Troy Hills, NJ	1	$6.4M	50
BioMarin	1997	4.6	San Rafael, CA	4	$2.9B	2,581
Insmed	1988	4.9	Bridgewater, NJ	1	$363.7M	373
Ophthotech	2007	4.5	New York, NY	1	$210.0M	58
Intermune	-	4.5	Brisbane, CA	1	$70.3M	353
Spectrum Pharmaceuticals	2002	4.4	Henderson, NV	3	$10.1M	235
CyLex	1994	3.7	Columbia, MD	1	$3.1M	200
Onyx Pharmaceuticals	1992	4.8	South San Francisco, CA	2	$362.2M	500

Rate SI-BONE's competitiveness in the market.

SI-BONE salaries vs competitors

Among SI-BONE competitors, employees at Onyx Pharmaceuticals earn the most with an average yearly salary of $95,378.

Compare SI-BONE salaries vs competitors

Company	Average salary	Hourly salary	Salary score
SI-BONE	$74,689	$35.91	-
SIG Medical	$65,016	$31.26	-
St. Louis Spine Surgery Center	$46,715	$22.46	-
Globus Medical	$78,407	$37.70	-
PDL BioPharma	$48,962	$23.54	-
Kyphon	$71,077	$34.17	-

Compare SI-BONE job title salaries vs competitors

Company	Highest salary	Hourly salary
SI-BONE	$130,305	$62.65
SIG Medical	$179,057	$86.08
Ophthotech	$171,457	$82.43
St. Louis Spine Surgery Center	$160,207	$77.02
Novartis Consumer Health Inc	$128,242	$61.65
Kyphon	$114,100	$54.86
Insmed	$97,728	$46.98
Intermune	$94,319	$45.35
Onyx Pharmaceuticals	$90,029	$43.28
BioMarin	$86,893	$41.78
PDL BioPharma	$76,185	$36.63
CyLex	$68,213	$32.79
Globus Medical	$68,194	$32.79
Spectrum Pharmaceuticals	$61,839	$29.73

Do you work at SI-BONE?

Is SI-BONE able to compete effectively with similar companies?

SI-BONE jobs

SI-BONE demographics vs competitors

Compare gender at SI-BONE vs competitors

Job title	Male	Female
PDL BioPharma	46%	54%
Spectrum Pharmaceuticals	48%	52%
BioMarin	50%	50%
Globus Medical	66%	34%
SI-BONE	-	-

Male

Female

100%

75%

50%

25%

SI-BONE

Globus Medical

BioMarin

Spectrum Pharmaceuticals

PDL BioPharma

25%

50%

75%

100%

Compare race at SI-BONE vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
BioMarin	43%	20%	8%	23%	7%	9.6
Globus Medical	66%	13%	10%	8%	3%	9.5
PDL BioPharma	54%	15%	7%	19%	4%	9.3
Spectrum Pharmaceuticals	51%	23%	9%	13%	5%	9.8

SI-BONE and similar companies CEOs

CEOBio

Jean Jacques Bienaime

BioMarin

Jean-Jacques Bienaime is a Board Member at Biotechnology Innovation Organization - BIO, Director at INCYTE CORP, and Chairman/CEO at BioMarin Pharmaceutical Inc and is based in Novato, California. He has experience at Rhône Poulenc Rorer and has worked as President/CEO at GENENCOR INTERNATIONAL INC, Board Member at NeurogesX Inc, and Marketing Director at Genentech. Jean attended ESCP Europe, Ecole Superieure de Commerce de Paris between 1974 and 1976, and University of Pennsylvania.

Daniel T. Scavilla

Globus Medical

A Strategic and Operational CFO with broad & deep geographic and business experience in Pharmaceutical, Biotech, Medical Device & Consumer Goods leading international markets worldwide in Financial operations, General Management, Information Technology, Procurement & Facilities. A strategic thinker partnering with leadership to develop long-range plans and deliver business & financial results through fact-based decision support, developing diverse cross-functional talent and implementing comprehensive metrics. Identify and sponsor change through P&L efficiencies, improved cash flow and new business models, fueling profit growth and margin expansion. Appling this approach to lead “beyond the numbers” with broad business acumen to impact the business.Recognized as a thought leader and business partner with a hands-on approach going beyond the financial leader role, a strong communicator who sorts through complexity and asks the right questions, willing to challenge the status quo & lead transformational change. Develop global finance organizations, placing leaders beyond the finance function.Experienced Management Board member of various sized healthcare, life science and consumer goods companies from start-up to multi-billion dollar global market leaders, driving high-growth businesses, improving turn-arounds and acquisition integration. Led financial organizations from 5 to 200 employees.Areas of expertise:Growth Strategies | Global Leadership | Board Member | Fact-Based Decision Support | Strategic & Financial Planning | Worldwide P&L Management | International Finance | Cost Accounting | Competitive Intelligence | Talent DevelopmentAdditional skills:Internal Financial Controls | Financial & Portfolio Analysis | Tax Planning | International Treasury Functions | Capital Structure & Cash Management | Mergers & Acquisition | Project Management | Investor Relations | New Product Launches | Acquisition Integration

William H. Lewis J.d

Insmed

Glenn P. Sblendorio

Ophthotech

Christopher Stone

PDL BioPharma

Joseph W. Turgeon

Spectrum Pharmaceuticals

Joe Turgeon is a President, COO at SPECTRUM PHARMACEUTICALS INC.

Richard Mott (Rich)

Kyphon

Richard 'Rich' Mott is a Chairman at Conventus Orthopaedics Inc, President/CEO at Kyphon, and Board Member at Vertiflex. He has worked as Board Member at Alfred University, Board Member at Conventus Orthopaedics Inc, and VP/General Manager at Greatbatch Scientific. Richard attended Alfred University and Harvard University.

Brad L Stewart

CyLex